Cryonine is an initiative by Cloudnine, to enable parents to preserve their baby’s cord blood cells at birth and give them the unique opportunity to safeguard the health of their loved ones. Enabled by Cryoviva, one of the experts in stem cell banking providing high-quality umbilical cord blood stem cell processing and storage for both private and social banking, Cryonine provides a superlative ecosystem for end-to-end stem cell preservation.
The cord blood is collected after your baby is delivered. The cord is clasped and the baby is separated from the cord and thereafter moved from the birthing area. The doctor collects the cord blood by inserting a needle into the cord vein and then draining the blood into the blood bag. The procedure is completely painless and risk-free for the mother as well as the baby. The whole collection process takes around 2 to 3 minutes after the delivery.
With a unique and highly advanced storage technology, you can have bio-insurance for the life of your newborn baby with Cloudnine’s Stem cell banking facility. You get only one opportunity to collect cord blood stem cells. Stem cells in your baby’s cord blood have the potential to be used in the treatment of many diseases today. Stem cells could be used to treat haematopoietic and genetic disorders. In a cord blood transplant, stem cells are infused into a patient’s bloodstream where they go to work - healing and repairing damaged cells and tissue. Upon successful engraftment of the stem cells, the patient’s blood and immune system are regenerated.
There is a wide range of diseases that are treatable with stem cells derived from cord blood and other sources of similar types of stem cells e.g. leukaemia, lymphoma, sickle cell anaemia and many other diseases. As the science of transplant continues to advance, new diseases are being treated with cord blood transplants.
So if you are considering cord blood preservation at a Stem Cell banking hospital in India, with its comprehensive ecosystem, Cloudnine gives you the best experience.
Cord blood is the blood that remains in the umbilical cord following the birth of a baby and after the umbilical cord is cut. It contains haematopoietic (blood) stem cells, rare cells normally found in the bone marrow. Haematopoietic stem cells (HSCs) can make every type of cell in the blood – red cells, white cells and platelets. They are responsible for maintaining blood production throughout our lives.
Cord blood stem cells can replace and regenerate damaged or diseased bone marrow, help in the treatment of blood cancers, and have the potential to be used for cellular therapy and regenerative medicine.
Stem cell storage means the collection and cryopreservation of stem cells in umbilical cord blood and tissue for future use in stem cell treatments or clinical trials. Storage can either be for the exclusive use of the baby and their family or available for use by anyone
What are the current uses for my baby’s stem cells and how could they be used in the future?
Currently, stem cells from cord blood are used in therapies for more than 85 different blood and immune diseases including Leukaemia, Neuroblastoma, and Sickle Cell Anaemia. They are also being investigated in thousands of clinical trials for use in regenerative medicine, including many currently incurable conditions such as heart disease, Alzheimer’s, diabetes, brain injury and many more.
A parent can use their child’s cord blood for treatment as long as there is an HLA (Human leukocyte Antigen) match between the two individuals.
A newborn’s cord blood can be used by other family members, including siblings, parents, and grandparents as long as there is an HLA (Human leukocyte Antigen) match between the two individuals.
For a perfect stem cell match for all of your children, you should save the stem cells from each of their births. However, any one of your children’s cord blood and tissue stem cells will have a 1 in 4 chance of being a perfect match for their siblings and a 3 in 4 chance of being a usable match.
After your baby is born, your obstetrician will first clamp and cut the umbilical cord, then insert a needle into the umbilical cord to collect the blood in a special bag. It is a completely painless process for both the baby and the mother.
First, the patient receives chemotherapy/radiotherapy to kill the diseased cells and malfunctioning bone marrow. Then transplanted blood stem cells are put into their bloodstream intravenously. The transplanted stem cells find their way into the bone marrow, where they begin producing new, healthy blood cells and differentiate into three blood cell types – red, white and platelets. The differentiation initiates the regeneration of the patient’s blood and immune system.
Studies are still being conducted but as of now, research indicates that the length of cryopreservation has had little impact on the recovery of viable cells and engraftment ability and shows that umbilical cord blood is in no way significantly affected by the length of cryopreservation.
